Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: question - any serious answers. please

"They are going into the company treasury, so they are still counted as part of the outstanding shares."

Not true. They are not considered outstanding. If they were there would be a lot less incentive for the buybacks.

 

Share
New Message
Please login to post a reply